“…Nowadays, absorbable sutures in the market are Dexon (polyglycolic acid), Vicryl (polyglactin 910), Monocryl (polyglecaprone 25), Maxon (polyglyconate), PDS II (PDO, polydioxanone), Surgisorb M (PLC, 75/25 poly( l -lactide- co -ε-caprolactone)), and MonoMax (PHB, poly-4-hydroxybutyrate), which possess 40–60, 60–90, 90–120, 180, 200, and 400 days of complete absorption, respectively. − Among these sutures, PDO, PLC, and PHB are classified as long-term absorbable monofilament sutures. Although PLC copolymers (Figure ) have been reported in the literature for use in a wide range of biomedical applications such as drug delivery systems, barrier membranes, absorbable nerve guides, bioadhesives, and scaffolds for tissue engineering, relatively little attention has been paid to absorbable sutures, possibly because of their slow rate of absorption (typically > 12 months) in the human body. − However, for use with the specific tissues or organs such as tendon and ligament repairs or abdominal wall closure, where slow absorption is required, PLC copolymers have been shown to be effective and versatile materials that can be tailored through their composition to meet the specific property requirements of a given application. − …”